Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 4/2002

01-05-2002 | Originales Breves

Potential complications of the growing teratoma syndrome in patients with advanced germ-cell tumors: description of three cases

Authors: Jorge Aparicio, Regina Gironés, José Alejandro Pérez-Fidalgo, Verónica Calderero, Roberto Díaz, Joaquín Montalar

Published in: Clinical and Translational Oncology | Issue 4/2002

Login to get access
Metadata
Title
Potential complications of the growing teratoma syndrome in patients with advanced germ-cell tumors: description of three cases
Authors
Jorge Aparicio
Regina Gironés
José Alejandro Pérez-Fidalgo
Verónica Calderero
Roberto Díaz
Joaquín Montalar
Publication date
01-05-2002
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 4/2002
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02717677

Other articles of this Issue 4/2002

Clinical and Translational Oncology 4/2002 Go to the issue

Editorial

Multidrug transporters in cancer resistance

Notas clínicas

Pancreatitis aguda inducida por L-asparraginasa

Notas Clínicas

Deletion 6q and +X in one primary central nervous system lymphoma (PCNSL) arising in a patient without immune defects

Originales

Second-line chemotherapy with weekly paclitaxel in patients with advanced non-small-cell lung cancer

Sección docente

Radiotherapy and tumour hypoxia

Originales

Hemipelvectomía interna
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits